These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34477274)

  • 21. A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy.
    Pal RP; Ahmad R; Trecartan S; Voss J; Ahmed S; Bazo A; Lloyd J; Walton TJ
    J Urol; 2018 Aug; 200(2):302-308. PubMed ID: 29477717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [MRI of the prostate].
    Nörenberg D; Solyanik O; Schlenker B; Magistro G; Ertl-Wagner B; Clevert DA; Stief C; Reiser MF; D'Anastasi M
    Urologe A; 2017 May; 56(5):665-677. PubMed ID: 28424829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy.
    Perrin A; Venderink W; Patak MA; Möckel C; Fehr JL; Jichlinski P; Porcellini B; Lucca I; Futterer J; Valerio M
    Urol Oncol; 2021 May; 39(5):297.e9-297.e16. PubMed ID: 33341358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of complications rates between multiparametric magnetic resonance imaging-transrectal ultrasound (TRUS) fusion and systematic TRUS prostatic biopsies.
    Queiroz MRG; Falsarella PM; Mariotti GC; Lemos GC; Baroni RH; Mussi TC; Garcia RG
    Abdom Radiol (NY); 2019 Feb; 44(2):732-738. PubMed ID: 30255444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micro-Ultrasound-Guided vs Multiparametric Magnetic Resonance Imaging-Targeted Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-Analysis.
    Sountoulides P; Pyrgidis N; Polyzos SA; Mykoniatis I; Asouhidou E; Papatsoris A; Dellis A; Anastasiadis A; Lusuardi L; Hatzichristou D
    J Urol; 2021 May; 205(5):1254-1262. PubMed ID: 33577367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
    Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
    J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiparametric MRI in Active Surveillance of Prostate Cancer: An Overview and a Practical Approach.
    Lee CH; Tan TW; Tan CH
    Korean J Radiol; 2021 Jul; 22(7):1087-1099. PubMed ID: 33856136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Joint Prostate Cancer Detection and Gleason Score Prediction in mp-MRI via FocalNet.
    Cao R; Mohammadian Bajgiran A; Afshari Mirak S; Shakeri S; Zhong X; Enzmann D; Raman S; Sung K
    IEEE Trans Med Imaging; 2019 Nov; 38(11):2496-2506. PubMed ID: 30835218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiparametric magnetic resonance imaging-targeted prostate biopsy: present and future of the prostate cancer diagnostic pathway.
    Manfredi M; DE Luca S; Russo F
    Minerva Urol Nephrol; 2021 Feb; 73(1):128-129. PubMed ID: 33764029
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 3: Targeted Biopsy.
    Venderink W; Bomers JG; Overduin CG; Padhani AR; de Lauw GR; Sedelaar MJ; Barentsz JO
    Eur Urol; 2020 Apr; 77(4):481-490. PubMed ID: 31791623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards a judicious use of perilesional biopsy in the era of MRI-targeting, parting of the ways from systematic prostate biopsy.
    Padhani AR; Raman SS; Schoots IG
    Eur Radiol; 2022 Nov; 32(11):7491-7493. PubMed ID: 36074267
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnostic accuracy of multiparametric magnetic resonance imaging combined with clinical parameters in the detection of clinically significant prostate cancer: A novel diagnostic model.
    Ippolito D; Querques G; Pecorelli A; Perugini G; Roscigno M; Da Pozzo LF; Maino C; Sironi S
    Int J Urol; 2020 Oct; 27(10):866-873. PubMed ID: 32713070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A deep dive into understanding tumor foci classification using multiparametric MRI based on convolutional neural network.
    Zong W; Lee JK; Liu C; Carver EN; Feldman AM; Janic B; Elshaikh MA; Pantelic MV; Hearshen D; Chetty IJ; Movsas B; Wen N
    Med Phys; 2020 Sep; 47(9):4077-4086. PubMed ID: 32449176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Certification in reporting multiparametric magnetic resonance imaging of the prostate: recommendations of a UK consensus meeting.
    Barrett T; Padhani AR; Patel A; Ahmed HU; Allen C; Bardgett H; Belfield J; Brizmohun Appayya M; Harding T; Hoch OS; Keanie JY; Liyanage SH; Papoutsaki MV; Punwani S; Robinson MJC; Rajesh A; Stafurth JN; van der Meulen J; Richenberg J
    BJU Int; 2021 Mar; 127(3):304-306. PubMed ID: 33113258
    [No Abstract]   [Full Text] [Related]  

  • 36. The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.
    Recabal P; Assel M; Sjoberg DD; Lee D; Laudone VP; Touijer K; Eastham JA; Vargas HA; Coleman J; Ehdaie B
    J Urol; 2016 Aug; 196(2):374-81. PubMed ID: 26920465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Performance of Multiparametric Magnetic Resonance Imaging and Fusion Targeted Biopsy to Detect Significant Prostate Cancer.
    Hoffmann MA; Taymoorian K; Ruf C; Gerhards A; Leyendecker K; Stein T; Jakobs FM; Schreckenberger M
    Anticancer Res; 2017 Dec; 37(12):6871-6877. PubMed ID: 29187467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Multimodal Algorithms for the Segmentation of Multiparametric MRI Prostate Images.
    Nai YH; Teo BW; Tan NL; Chua KYW; Wong CK; O'Doherty S; Stephenson MC; Schaefferkoetter J; Thian YL; Chiong E; Reilhac A
    Comput Math Methods Med; 2020; 2020():8861035. PubMed ID: 33144873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Step-by-Step: Fusion-guided prostate biopsy in the diagnosis and surveillance of prostate cancer.
    Nassiri N; Beeder L; Nazemi A; Asanad K; Um J; Gill I; Oishi M; Palmer SL; Aron M; Ukimura O; Abreu ALC
    Int Braz J Urol; 2019; 45(6):1277-1278. PubMed ID: 31268636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Optimal Prostate Biopsy in the Era of Multiparametric Magnetic Resonance Imaging.
    Smigelski M; Taneja SS
    Eur Urol Oncol; 2023 Feb; 6(1):56-57. PubMed ID: 36336612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.